Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes
- 5 April 2003
- journal article
- research article
- Published by Wiley in Brain Pathology
- Vol. 13 (2) , 133-143
- https://doi.org/10.1111/j.1750-3639.2003.tb00013.x
Abstract
No data exist on angiogenic patterns and their prognostic impact in human glioblastoma. Such data are relevant for translation of antiangiogenic therapies into clinical applications. Using immunohistochemistry for CD34, we assessed vascular patterns in 114 primary glioblastomas. Vascular patterns comprised unevenly distributed glomeruloid/garland‐like/clustered bizarre vascular formations and evenly distributed delicate capillary‐like microvessels (“classic” vascular pattern). The combination of low content of bizarre vascular formations and prominent classic vascular pattern (n=29) was an independent factor for longer survival (p= 0.006, Cox regression), as well as postoperative high Karnofsky performance status (p=0.005). In patients with a prominent classic vascular pattern, there was no difference of MIB1 labeling index whereas microvessel density and apoptotic index (TUNEL) were significantly higher as compared to all other patients (p<0.05). In addition, diffuse expression of hypoxia‐inducible factor (HIF)‐1α and strong expression of vascular endothelial growth factor were more common (p<0.05, Chi‐square test). FISH revealed loss of chromosomes 1p and 19q only in 1/7 long‐time survivors with classic pattern. We conclude that vascular patterns in primary glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins. Our findings denote for the first time distinct angiogenic subtypes of human glioblastoma which may prove relevant for anti‐angiogenic therapy approaches.Keywords
This publication has 31 references indexed in Scilit:
- Tumor angiogenesis - a new therapeutic target in gliomasActa Neurologica Scandinavica, 2009
- Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines*†Medical and Pediatric Oncology, 2001
- Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapyGene Therapy, 2001
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenograftsNature, 1999
- A Quantitative Analysis of Vascularization and Perfusion of Human Glioma Xenografts at Different Implantation SitesMicrovascular Research, 1999
- Early Induction of Angiogenetic Signals in Gliomas of GFAP-v-src Transgenic MiceThe American Journal of Pathology, 1999
- Oxygen-regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-inducible Factor-1αJournal of Biological Chemistry, 1999
- Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1αGenes & Development, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958